Session: Poster Abstracts: Other


Wednesday, 6 April 2005: 4:00 PM-7:00 PM
Exhibit Hall C (Marriott Wardman Park Hotel)
Poster Abstracts: Other

		Under diagnosis & treatment of osteoporosis: what's happening at an academic community hospital Sallie J. Urffer, LPTA, MHA, Albert Peters, DO
		Effect of Hip Fracture Risk Information on Osteoporosis Treatment by Primary Care Physicians Joan M. Neuner, MD, MPH, Puroshottam W. Laud, Marilyn M. Schapira
		Cost Analysis of Osteoporotic Treatments: A Managed Care Perspective D.I. Brixner, PhD, Natalie N. Borisov, PhD, Russel T Burge, PhD, Michael Steinbuch, PhD
		Risedronate 15 Mg/Day for 2 Years Demonstrates an Excellent Safety Profile over a Wide Range of Renal Function Paul D. Miller, MD, Simon H. Magowan, MD, Ian Barton, BSc, John F. Beary, MD, Clifton O. Bingham III, MD, Silvano Adami, MD
		Health Care Disparities in Postmenopausal Women Referred for DEXA Irene Hamrick, MD, Kenneth K. Steinweg, Doyle M. Cummings, Lauren M. Whetstone
		Bone histomorphometry following 10 years alendronate treatment K.E. Ensrud, MD, S Diem, D. Kimmel, DDS, PhD, RR Recker, MD, P. Masarachia, MS, A. Lombardi, M.D., L. Wehren, MD
		The effect of teriparitide [human parathyroid hormone (1-34] therapy on fracture healing in charcot neuroarthropathy of the lower extremity Thomas Brosky, DPM, Christopher Recknor, MD, Stephanie Grant